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Abstract. To detect IgG antibody in the serodiagnosis of visceral leishmaniasis (VL), a recombinant antigen rK39,
which is part of a Leishmania chagasi kinesin-related protein, has been used successfully and showed high sensitivity and
specificity. We report production of a recombinant protein rKRP42, which is part of an L. donovani kinesin-related
protein and a homolog of rK39, and its application in an enzyme-linked immunosorbent assay (ELISA) for the diagnosis
of VL. When rKRP42 and rK39 were compared, amino acid sequence analysis showed 89.3% identity and 98.7%
homology, with rKRP42 having 39 more amino acids than rK39. The ELISA using rKRP42 showed a sensitivity of 94.6%
(70 positive samples among 74 from VL patients) and a specificity of 99.3% (148 negative samples among 149 samples
from Japanese controls), whereas the sensitivity of the commercial rK39 dipstick test was 93.2% (69 positive samples
among 74 from patients with VL). The rKRP42 is a promising new antigen in developing immunodiagnostic methods
for VL.
Visceral leishmaniasis (VL) or kala-azar is caused by an
intracellular protozoan parasite of the Leishmania donovani
complex and is considered as one of the most neglected dis-
eases.1 More than 47 countries are currently affected, with at
least 200 million people at risk.2 Approximately 90% of the
500,000 estimated annual cases of VL occur in rural areas of
Bangladesh, India, Nepal, Sudan, and Brazil in some of the
world’s poorest regions. This disease accounts for 75,000
deaths annually.3
Most VL cases in peripheral health facilities are still treated
on the basis of clinical suspicion and/or the result of an inad-
equately sensitive and specific formol-gel test (aldehyde
test).4 However, classic clinical features of VL are shared by
several other endemic diseases such as malaria, disseminated
tuberculosis, and enteric fever, which are also common in
many of the areas endemic for VL. Demonstration of the
causative parasites in aspirates from lymph nodes, bone mar-
row, and spleen is the most specific diagnosis, with the sen-
sitivities of 56.3%, 67.1%, and 93.3%, respectively.5 These
techniques are invasive and require skilled personnel and
equipped facilities. Because of the high mortality if left un-
treated and the serious toxicity of the most widely used first-
line drug, sodium stibogluconate, a highly sensitive and spe-
cific diagnostic method that is simple, inexpensive, and appli-
cable in rural settings is urgently needed.
Several serologic tests, such as enzyme-linked immunosor-
bent assays (ELISAs) with crude or recombinant antigens6–8
and the direct agglutinin test (DAT),9,10 have provided useful
diagnostic results. Recently, a recombinant antigen rK39,
which is part of an L. chagasi kinesin-related protein, has
been widely evaluated by ELISA or in a dipstick format.11,12
Although the antigen has been reported satisfactory, results
varied considerably in different disease-endemic areas. Thus,
it was desirable to develop new antigens for comparison. We
report the production of recombinant protein rKRP42, which
is part of an L. donovani kinesin-related protein and a ho-
molog of rK39 and evaluation of this antigen in an ELISA
with serum samples for the diagnosis of VL.
Leishmania donovani strain DD8, isolated from a Bang-
ladeshi patient, was used.13 Promastigotes were cultured and
harvested as described previously.14 Genomic DNA was ex-
tracted from promastigotes by phenol extraction method. To
obtain the gene coding the rK39 homolog, polymerase chain
reaction (PCR) amplification was performed by using primers
(rK39 sense, 5-GAGCTCGCAACCGAGTGGGAGGAC-
3 and rK39 antisense, 5-CTGGCTCGCCAGCTCCGCG-
GCGCG-3) with Pfu DNA polymerase (Stratagene, La
Jolla, CA) and L. donovani genomic DNA. The amplified
PCR product was subjected to electrophoresis on an agarose
gel, purified with QIAquick Gel Extraction Kit (Qiagen,
Hilden, Germany), and ligated into the EcoRV site of the
pBluescript KS(-) vector (Stratagene). The PCR product was
confirmed to have 1,011 basepairs (GenBank accession no.
AB256033). Further PCR amplification was performed with
the sequenced-confirmed plasmid containing the rK39 ho-
molog gene, known as rKRP42, as a template by using
primers (rK39 sense, 5-GAGCTCGCAACCGAGTGG-
GAGGAC-3 and 6His/EcoRI-rK39 antisense, 5-GTGAT-
GGTGATGGTGATGGAATTGATCCTGGCTCGC-
CAGCTC-3) with Pfu DNA polymerase. The PCR product
coding rKRP42 and a six-histidine amino acid (6His) tag was
cloned into the in Sma I site of the pTYB12 expression vector
(New England Biolabs, Beverly, MA). The rKRP42 was pu-
rified with QIAexpress kit (Qiagen) and IMPACT™-CN Sys-
tem (New England Biolabs) according to the manufacturer’s
protocols.
Briefly, Escherichia coli cells were cultured with Luria-
Bertani medium containing 100 g/mL of ampicillin. Protein
expression was induced with isopropyl thio--galactoside at a
final concentration of 0.4 mM at 16°C for 16 hours. The cells
were then harvested and resuspended in lysis buffer (50 mM
sodium phosphate, pH 8.0, 300 mM NaCl, 10 mM imidazole,
and 0.1% Triton X-100). After sonication and centrifugation,
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the clarified cell extract was purified on an Ni-NTA column
(Qiagen). The column was washed with the Ni-NTA wash
buffer, and the extraction fraction was eluted with Ni-NTA
elution buffer. The eluate was then purified on a chitin col-
umn (New England Biolabs) and washed with chitin column
wash buffer. The column was kept with cleavage buffer con-
taining dithiothreitol (DTT) at 16°C for 16 hours, and then
rKRP42 was eluted with cleavage buffer without DTT (Figure
1). The rKRP42 antigen contains 337 amino acids and is one
repeat (39 amino acids) longer than the rK39 antigen (Figure 2).
The amino acid sequence of rKRP42 showed 89.3% identity and
98.7% homology with rK39 antigen.
We performed an ELISA with rKRP42 antigen as follows.
Flat-bottomed 96-well microtiter plates (MaxiSorp™; Nunc,
Roskilde, Denmark) were coated with 1 g/mL (100 L/well)
of rKRP42 antigen and incubated overnight at 4°C. After
blocking with casein buffer (1% casein in 0.05 M Tris-HCl
buffer, 0.15 M NaCl, pH 7.6) for two hours at room tempera-
ture, 100 L of serum (1:4,000 dilution in casein buffer) was
added to the wells and incubated for one hour at 37°C. After
four washes with phosphate-buffered saline, pH 7.4, contain-
ing 0.05% Tween 20, peroxidase-conjugated goat anti-human
IgG (Tago, Camarillo, CA), diluted 1:4,000 with casein buffer
was added and incubated for one hour at 37°C. After four
washes, 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
substrate (Kirkegaard and Perry Laboratories Inc., Gaithers-
burg, MD) was added and incubated for one hour at room
temperature. The optical density was measured at 415 nm and
at 492 nm as reference. Each sample was assayed in duplicate.
If the absorbance values of the duplicate samples differed by
> 40% from their average, the sample was retested. Antibody
levels were expressed arbitrarily as units, which were was
estimated from a standard curve constructed with serially di-
luted positive sera. The cutoff point for IgG to rKRP42 was
calculated as the mean plus three standard deviations of log
(unit + 1) values of the non-endemic healthy controls
(NEHCs). The anti-logarithmic value was 109.4 units.
The rK39 antigen-based dipstick test (InBios International,
Seattle, WA) was carried out according to the manufacturer’s
instruction. Briefly, 20 L of serum was added to a test strip.
The strip was placed in a well of 96-well microtiter plate, and
two drops of chase buffer solution were added to each well.
The test result was read within 10 minutes after addition of
serum. Even a weak line was considered positive.
Seventy-four serum samples from defined VL patients col-
lected from different medical college hospitals in Bangladesh
were used to compute sensitivities of the rKRP42 ELISA and
rk39 dipstick test. Among the 74 patients, 32 were confirmed
parasitologically: Leishman-Donovan bodies were detected in
smears of splenic aspirates (18 patients) or bone marrow as-
pirates (6 patients), and promastigotes were detected in 8
patients after inoculation of aspirate materials into Novy,
MacNeal, and Nicolle medium. Of the other 42 clinically con-
firmed patients, 27, 7, and 8 were positive by conventional
DAT, aldehyde test, and rK39 dipstick test, respectively. At
the time of sample collection, all patients were being treated
with sodium antimony gluconate at the recommended dose of
the World Health Organization.15 Sera containing preserva-
tive (NaN3) at a concentration of 0.1% (w/v) were trans-
ported to Japan at ambient temperature and then stored at
−40°C. Seventy-two samples from healthy Japanese individu-
als were used as NEHCs to determine the cutoff value. An-
other 149 NEHC samples were used to determine the speci-
ficity of the rKRP42 ELISA.
The study was reviewed and approved by the Ethics Com-
mittee of Aichi Medical University School of Medicine, Ja-
pan, and the Ethical Review Committee of the Bangladesh
Medical Research Council.
FIGURE 1. Purification of rKRP42 from induced Escherichia coli
clone cells by using Ni-NTA and chitin columns. Protein samples
were subjected to sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis and visualized by staining with Coomassie brilliant blue.
Lane 1, Crude extraction from induced cells; lane 2, Ni-NTA column
flow through fraction; lane 3, Ni-NTA column wash fraction; lane 4,
Ni-NTA column elution fraction with the elution buffer; lane 5, chitin
column flow through fraction; lane 6, chitin column wash fraction;
lane 7, chitin column rinse fraction with the cleavage buffer; lane 8,
chitin column elution fraction after 16-hour cleavage reaction. kDa
kilodaltons.
FIGURE 2. Comparison of amino acid sequences of rKRP42 and
rK39 antigens in a single-letter code. Asterisks indicate identical resi-
dues and periods indicate conservative amino acid substitutions.
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The ELISA with rKRP42 antigen showed a sensitivity of
94.6% (70 positive samples among 74 VL samples) and a
specificity of 99.3% (148 negative samples among 149 Japa-
nese controls) (Figure 3). The sensitivity of the rK39 dipstick
was 93.2% (69 positive samples among 74 VL samples). Be-
cause of the high specificities already reported for the rK39
dipstick test (97–100%),11,16–19 Japanese controls were not
tested. There are three parasitologically confirmed cases who
were negative by both the ELISA and dipstick test. In a sepa-
rate study, these three cases showed negative results with a
conventional serum-based DAT, a urine-based ELISA with
soluble antigen of acetone-treated promastigotes,14 and a
urine-based DAT.20 One ELISA-positive, dipstick-negative
sample had a relatively low antibody titer of 202.0 units. We
could not determine the specificity for other diseases such as
malaria, tuberculosis, and cutaneous leishmaniasis and for
healthy controls from a disease-endemic area because of a
lack of serum samples.
A variety of immunologic methods have been used to di-
agnose VL. Among others, the rK39 dipstick test is used be-
cause of its ease in handling, quick results, and high sensitivity
and specificity. However, the sensitivity varied considerably
in different disease-endemic areas. In India and Nepal,16–18
the test showed the highest sensitivity (100%), but the sensi-
tivity was significantly lower in Venezuela (88%),21 southern
Europe (71.4%),19 and Sudan (67%).22 This variation may be
due to differences in the test accuracy between subspecies of
L. donovani complexes, genetic differences in individual pa-
tients or in racial subgroups, and epidemiologic factors such
as length or severity of diseases.23 It would be worthwhile to
test the new rKRP42 antigen in different geographic areas.
Some persons with VL do not show any clinical manifesta-
tions. Khalil and others24 reported that in eastern Sudan the
ratios of clinical and subclinical cases in 1994–1995 and 1995–
1996 in Um-Salala village were 1.2:1 and 2.6:1, respectively,
and in Mashrau Koka village were 1:11 and 1:2.5, respectively.
In another study conducted in Bihar State, India, 69% of
asymptomatic seropositve cases detected by the rK39 ELISA
and dipstick test developed kala-azar within one year,25 which
suggested that that many of the asymptomatic cases were in a
pre-clinical state. In predicting possible clinical cases, an
ELISA that is quantitative would be more advantageous than
a dipstick format; high antibody titers or an increase in anti-
body titers with time could be indicative of possible clinical
cases. Such early diagnosis will have a practical importance
now that oral treatment with miltefosine has become avail-
able.26 Measurements of Leishmania-specific IgG, IgM, IgE,
and IgG subclasses were also found to be useful as markers
for active VL cases and for monitoring effective treat-
ment.27,28 The rKRP42 ELISA for IgG antibody can be used
in clinical follow-up studies based on antibody titers and
modified for various immunoglobulin classes.
Recently, the use of urine for blood has been considered
valuable because of its ease in sample collection, and urine-
based tests for the diagnosis of VL and other parasitic dis-
eases have been reported.14,20,29,30 Before establishing a
urine-based immunodiagnostic method with a new antigen,
the antigen must be first evaluated with serum samples. In a
field study, when many borderline positive results can be ex-
pected, the serum-based rKRP42 ELISA can be a valuable
reference.
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